Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Health to Sell 3 Million Shares

NEW YORK (GenomeWeb News) - Genomic Health plans to sell 3 million shares of its common stock through an underwritten public offering, the company said yesterday.
 
The company said it will use the proceeds from the sale for general corporate purposes, marketing, R&D, and for expanding its labs.
 
Genomic Health said it will grant underwriters a 30-day option to buy an additional 450,000 shares.
 
The company's stock closed at $15.79 on Monday.
 
J.P. Morgan Securities will be sole book-runner for the offering, and Lehman Brothers, Piper Jaffray, and JMP securities will be co-managers.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.